0,996  0,001  Monophenol monooxygenase inhibitor
0,995  0,001  Chemoprotective
0,986  0,001  Carbonic anhydrase XIII inhibitor
0,980  0,001  Xanthine oxidase inhibitor
0,978  0,001  Antimutagenic
0,976  0,003  Mutagenic
0,968  0,001  Chemopreventive
0,961  0,001  Proliferative diseases treatment
0,951  0,001  Melanin inhibitor
0,951  0,005  Alpha-glucosidase inhibitor
0,945  0,001  Antihypoxic
0,937  0,002  NOS2 expression inhibitor
0,933  0,002  Caspase 9 stimulant
0,933  0,003  Antioxidant
0,929  0,001  Amylase inhibitor
0,931  0,003  TNF expression inhibitor
0,923  0,003  Antihypercholesterolemic
0,924  0,004  Carcinogenic
0,924  0,004  Transcription factor NF kappa B inhibitor
0,900  0,003  Radioprotector
0,895  0,003  Free radical scavenger
0,883  0,002  Sulfotransferase substrate
0,882  0,001  Cystathionine beta-synthase inhibitor
0,880  0,002  UGT1A9 substrate
0,878  0,003  Vasodilator, coronary
0,870  0,003  Genotoxic
0,869  0,003  DNA damaging
0,857  0,002  UGT1A1 substrate
0,861  0,010  Apoptosis agonist
0,852  0,004  Cardioprotectant
0,850  0,002  Mediator release inhibitor
0,846  0,004  Sensitization
0,844  0,002  Carbonic anhydrase VI inhibitor
0,848  0,009  Antiinflammatory
0,809  0,002  Antidote
0,797  0,007  Antidiabetic
0,797  0,007  Cyclophilin D inhibitor
0,770  0,004  Antiamyloidogenic
0,764  0,005  Amyloid beta aggregation inhibitor
0,760  0,004  NOS3 expression inhibitor
0,753  0,005  Antithrombotic
0,750  0,004  Hypoglycemic
0,749  0,005  Nitric oxide antagonist
0,747  0,004  Vascular (periferal) disease treatment
0,754  0,012  Teratogen
0,746  0,003  Ulceration
0,745  0,004  Skin whitener
0,746  0,006  Antibacterial
0,726  0,002  Antihemorrhagic
0,736  0,016  Antineoplastic (breast cancer)
0,719  0,005  Antiparasitic
0,717  0,004  Antihypertriglyceridemic
0,717  0,005  AR expression inhibitor
0,708  0,004  Apoptosis antagonist
0,707  0,012  Antileukemic
0,698  0,003  NOS3 expression enhancer
0,707  0,014  Embryotoxic
0,694  0,003  Antipruritic, allergic
0,692  0,006  Caspase 3 stimulant
0,687  0,001  Protein kinase stimulant
0,677  0,005  Angiogenesis stimulant
0,675  0,003  Antihypotensive
0,688  0,019  Antineoplastic (lung cancer)
0,672  0,005  UDP-glucuronosyltransferase substrate
0,671  0,004  Antihelmintic
0,669  0,005  Antipyretic
0,671  0,008  CTGF expression inhibitor
0,667  0,006  Hepatic disorders treatment
0,663  0,008  Spasmolytic
0,642  0,003  Beta glucuronidase inhibitor
0,647  0,010  Antineoplastic (cervical cancer)
0,642  0,005  Tumour necrosis factor alpha release inhibitor
0,645  0,017  CYP2C9 substrate
0,629  0,004  Hepatoprotectant
0,621  0,003  VCAM1 expression inhibitor
0,632  0,015  Cholesterol antagonist
0,621  0,007  Antiprotozoal (Leishmania)
0,618  0,008  UGT1A6 substrate
0,606  0,002  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,598  0,006  Antineoplastic (osteosarcoma)
0,603  0,012  Cytotoxic
0,584  0,002  Carbonic anhydrase XIV inhibitor
0,605  0,023  Antineoplastic (colorectal cancer)
0,594  0,017  Immunostimulant
0,588  0,019  Prostate cancer treatment
0,562  0,006  Carcinogenic, group 3
0,556  0,005  Non-steroidal antiinflammatory agent
0,561  0,015  Cytostatic
0,545  0,006  UGT2B4 substrate
0,540  0,002  Carbonic anhydrase VII inhibitor
0,564  0,025  Antineoplastic (colon cancer)
0,542  0,006  ICAM1 expression inhibitor
0,546  0,014  Antifungal
0,533  0,005  Lipid peroxidase inhibitor
0,542  0,018  Histamine release inhibitor
0,530  0,010  Vasodilator
0,506  0,005  Platelet adhesion inhibitor
0,522  0,027  Immunosuppressant
0,519  0,025  CYP2C19 substrate
0,512  0,020  Antineoplastic (pancreatic cancer)
0,504  0,014  Hypoxia-inducible factor 1 alpha inhibitor
0,492  0,003  Cyclooxygenase 3 inhibitor
0,495  0,009  P-glycoprotein inhibitor
0,501  0,019  Antineoplastic (brain cancer)
0,522  0,042  Alzheimer's disease treatment
0,487  0,009  Radiosensitizer
0,479  0,012  RNA-directed DNA polymerase inhibitor
0,486  0,022  Antiischemic
0,464  0,003  Carbonic anhydrase III inhibitor
0,473  0,012  Antineoplastic (liver cancer)
0,481  0,022  Antineoplastic (glioma)
0,460  0,002  Heat shock protein 70 antagonist
0,482  0,026  Antineoplastic (melanoma)
0,484  0,031  Respiratory analeptic
0,479  0,030  Antineoplastic (ovarian cancer)
0,464  0,022  Antineoplastic (multiple myeloma)
0,445  0,006  Alkylator
0,482  0,044  CYP3A4 substrate
0,463  0,025  Antiosteoporotic
0,451  0,014  Myocardial infarction treatment
0,440  0,006  Hemostatic
0,451  0,017  Antidiabetic symptomatic
0,451  0,017  DNA synthesis inhibitor
0,467  0,036  Stroke treatment
0,463  0,034  Bone diseases treatment
0,424  0,003  Nitric-oxide synthase stimulant
0,423  0,003  Antiviral (Influenza B)
0,420  0,004  AMP-activated protein kinase stimulant
0,454  0,038  CYP2C19 inhibitor
0,461  0,047  Antiprotozoal
0,437  0,023  CYP1A2 inhibitor
0,434  0,021  Antineoplastic (lymphoma)
0,416  0,010  DNA methylase inhibitor
0,407  0,006  Glutathione S-transferase substrate
0,405  0,008  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,403  0,010  Topoisomerase II inhibitor
0,421  0,029  Antineoplastic (non-small cell lung cancer)
0,415  0,025  Antineoplastic (glioblastoma multiforme)
0,403  0,014  Antiviral (Herpes)
0,432  0,046  Vasodilator, peripheral
0,386  0,003  Photosensitizer
0,399  0,020  Antineoplastic enhancer
0,413  0,036  Lipoprotein disorders treatment
0,394  0,020  Antiulcerative
0,410  0,041  Immunomodulator
0,365  0,005  Topoisomerase II alpha inhibitor
0,364  0,005  Dementia treatment
0,373  0,014  Antiviral (Influenza)
0,370  0,014  Antineoplastic (squamous cell carcinoma)
0,361  0,005  Vascular dementia treatment
0,380  0,028  Antineoplastic (renal cancer)
0,354  0,004  Aldose reductase inhibitor
0,359  0,011  UGT2B15 substrate
0,360  0,013  DNA methyltransferase I inhibitor
0,379  0,034  Interleukin 2 agonist
0,359  0,014  UGT1A3 substrate
0,379  0,043  Analeptic
0,346  0,010  Insulin sensitizer
0,337  0,004  Selectin antagonist
0,358  0,031  Transcription factor STAT inhibitor
0,420  0,094  Antineoplastic (solid tumors)
0,328  0,004  Carbonic anhydrase XII inhibitor
0,329  0,008  Antifungal enhancer
0,328  0,007  Interleukin 4 antagonist
0,323  0,008  Aldose reductase substrate
0,318  0,004  Antihelmintic (Trematoda)
0,361  0,048  CYP1A2 substrate
0,328  0,016  Peptidyltransferase inhibitor
0,315  0,004  Antiviral (Ebola)
0,314  0,004  Histone deacetylase stimulant
0,314  0,004  Histone deacetylase SIRT1 stimulant
0,344  0,035  Pyruvate kinase inhibitor
0,315  0,008  Expectorant
0,343  0,038  Antineoplastic (small cell lung cancer)
0,346  0,043  Huntington's disease treatment
0,307  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,329  0,030  Antineoplastic (sarcoma)
0,302  0,004  DNA repair enzyme inhibitor
0,329  0,034  Antineoplastic (lymphocytic leukemia)
0,301  0,011  Topoisomerase I inhibitor
0,295  0,005  Alcohol dehydrogenase inhibitor
0,338  0,048  Antidiabetic (type 2)
0,302  0,013  Acute respiratory distress syndrome (ARDS) treatment
0,304  0,018  Protein-tyrosine phosphatase inhibitor
0,305  0,019  Interferon gamma antagonist
0,291  0,005  Choleretic
0,338  0,060  Antimycobacterial
0,371  0,098  5 Hydroxytryptamine release inhibitor
0,323  0,050  Antineoplastic (endocrine cancer)
0,278  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,303  0,033  Septic shock treatment
0,287  0,018  Antiviral (Influenza A)
0,278  0,011  Antineoplastic antibiotic
0,290  0,024  Antipruritic, non-allergic
0,288  0,022  Neurotrophic factor enhancer
0,269  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,271  0,012  Gout treatment
0,282  0,024  Antineoplastic (carcinoma)
0,307  0,050  Platelet antagonist
0,307  0,054  Antiprotozoal (Trypanosoma)
0,256  0,004  Thioredoxin inhibitor
0,267  0,015  Aldehyde dehydrogenase inhibitor
0,270  0,018  MAO A inhibitor
0,298  0,049  Hypolipemic
0,320  0,071  CYP2D6 substrate
0,272  0,025  Antihelmintic (Nematodes)
0,293  0,049  Interleukin antagonist
0,310  0,067  Lipoxygenase inhibitor
0,257  0,015  Protein-tyrosine phosphatase 1B inhibitor
0,256  0,015  Chelator
0,247  0,010  Anticataract
0,238  0,004  Xanthine dehydrogenase inhibitor
0,242  0,010  Antifungal (Cryptococcus)
0,247  0,016  Antitussive
0,257  0,026  MAO inhibitor
0,257  0,028  Antineoplastic (gastric cancer)
0,259  0,031  Thrombolytic
0,244  0,018  Hexokinase inhibitor
0,228  0,004  Toll-Like receptor 4 antagonist
0,345  0,122  Antiarthritic
0,241  0,018  DNA polymerase I inhibitor
0,225  0,004  Fatty acid synthase inhibitor
0,226  0,005  Interleukin 12 antagonist
0,233  0,014  UDP-glucose 4-epimerase inhibitor
0,241  0,022  Alkaline phosphatase inhibitor
0,244  0,027  Cyclooxygenase inhibitor
0,280  0,064  Transcription factor STAT3 inhibitor
0,232  0,019  ATPase inhibitor
0,220  0,010  Uric acid excretion stimulant
0,230  0,024  Insulin secretagoues
0,227  0,026  Acetylcholinesterase inhibitor
0,207  0,009  Multidrug resistance-associated protein 1 inhibitor
0,220  0,023  Cell wall synthesis inhibitor
0,227  0,031  Phospholipase C inhibitor
0,204  0,012  Antibiotic
0,203  0,014  Falcipain inhibitor
0,201  0,013  Falcipain 2 inhibitor
0,219  0,031  Interleukin 6 antagonist
0,291  0,105  Antiprotozoal (Plasmodium)
0,215  0,030  NADPH oxidase inhibitor
0,212  0,027  Antirickettsial
0,195  0,013  Gastritis treatment
0,186  0,005  Phosphodiesterase 6D inhibitor
0,204  0,024  Cell adhesion inhibitor
0,183  0,004  Antibiotic Glycopeptide-like
0,207  0,029  Cyclooxygenase 2 inhibitor
0,252  0,077  Antineoplastic (bladder cancer)
0,205  0,032  Cyclooxygenase 1 inhibitor
0,195  0,023  Carcinogenic, group 2B
0,185  0,016  Antispirochetal
0,206  0,043  Restenosis treatment
0,176  0,017  Breast cancer-resistant protein inhibitor
0,175  0,017  Estrogen antagonist
0,192  0,034  SULT1A3 substrate
0,196  0,037  Antidiarrheal
0,226  0,071  Antiviral (HIV)
0,164  0,012  SULT1E1 substrate
0,186  0,038  Antinephritic
0,158  0,010  Antiviral (Rhinovirus)
0,171  0,023  Vanilloid 1 agonist
0,186  0,039  Antiprotozoal (Coccidial)
0,243  0,096  Antituberculosic
0,182  0,036  Psychosexual dysfunction treatment
0,152  0,010  T cell inhibitor
0,195  0,052  Liver fibrosis treatment
0,153  0,011  Estrogen agonist
0,155  0,014  Carbonic anhydrase V inhibitor
0,147  0,006  Na+ K+ transporting ATPase inhibitor
0,184  0,044  Carcinogenic, group 1
0,220  0,080  Cyclic AMP phosphodiesterase inhibitor
0,149  0,011  Carbonic anhydrase VA inhibitor
0,198  0,061  Antiviral (Hepatitis)
0,181  0,048  Antiacne
0,167  0,035  Antibacterial (Helicobacter pylori)
0,142  0,013  Interleukin 5 antagonist
0,141  0,014  CDC25A inhibitor
0,151  0,029  HDL-cholesterol increasing
0,129  0,009  Maillard reaction inhibitor
0,160  0,042  Retinoprotector
0,137  0,019  Transcription factor NF kappa B stimulant
0,186  0,068  UGT2B7 substrate
0,171  0,057  Hair growth stimulant
0,141  0,028  Creatine kinase inhibitor
0,120  0,008  Antimycoplasmal
0,125  0,014  Postmenopausal disorders treatment
0,122  0,012  Phosphodiesterase VI inhibitor
0,187  0,077  Wound healing agent
0,120  0,010  Phosphorylase inhibitor
0,125  0,016  Lipase inhibitor
0,111  0,005  Glucose-6-phosphate translocase inhibitor
0,109  0,004  Arginase inhibitor
0,121  0,016  Thioredoxin reductase inhibitor
0,148  0,043  DNA intercalator
0,119  0,015  HIV-1 integrase inhibitor
0,174  0,071  Antineoplastic (bone cancer)
0,115  0,013  Neuraminidase (influenza) inhibitor
0,121  0,019  ATPase (Vacuolar H+) inhibitor
0,122  0,022  Glutathione S-transferase inhibitor
0,116  0,016  Antiviral (Dengue virus)
0,135  0,036  Antineoplastic, alkylator
0,144  0,046  Growth stimulant
0,098  0,003  Sodium/glucose cotransporter 2 inhibitor
0,108  0,013  Neuraminidase inhibitor
0,208  0,113  Interleukin agonist
0,097  0,003  Cholesterol absorption inhibitor
0,141  0,051  Antiviral (Hepatitis B)
0,132  0,045  5-Lipoxygenase inhibitor
0,096  0,010  Nitric oxide donor
0,115  0,029  Ornithine decarboxylase inhibitor
0,119  0,033  Actinic keratosis treatment
0,150  0,065  Mannose-6-phosphate isomerase inhibitor
0,107  0,025  Carbonic anhydrase inhibitor
0,117  0,035  Estrogen receptor beta antagonist
0,101  0,019  Prostaglandin EP2 antagonist
0,084  0,003  Sodium/glucose cotransporter inhibitor
0,086  0,005  Heparanase inhibitor
0,095  0,014  Protein 50S ribosomal subunit inhibitor
0,133  0,057  Antineoplastic (uterine cancer)
0,214  0,139  Metabolic disease treatment
0,101  0,031  Phosphofructokinase-1 inhibitor
0,107  0,037  NADH dehydrogenase inhibitor
0,218  0,150  Angiogenesis inhibitor
0,083  0,014  Leukotriene B4 antagonist
0,073  0,005  Antibiotic Aminoglycoside-like
0,126  0,058  Interleukin 1b antagonist
0,133  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,069  0,003  Sodium/glucose cotransporter 1 inhibitor
0,087  0,024  Carbonic anhydrase IX inhibitor
0,089  0,026  Antitreponemal
0,141  0,079  Antidiabetic (type 1)
0,085  0,024  CDC25B inhibitor
0,145  0,085  CF transmembrane conductance regulator agonist
0,061  0,006  Protein 30S ribosomal subunit inhibitor
0,100  0,048  Triose-phosphate isomerase inhibitor
0,088  0,036  Narcotic antagonist
0,151  0,100  Amyloid beta precursor protein antagonist
0,107  0,057  MAO B inhibitor
0,117  0,068  Cholesterol synthesis inhibitor
0,137  0,088  Cholinergic
0,123  0,075  Papain-like protease (SARS coronavirus) inhibitor
0,067  0,019  Alpha-mannosidase inhibitor
0,063  0,017  Estrogen receptor beta agonist
0,062  0,017  Glucose-6-phosphate isomerase inhibitor
0,078  0,033  Leukotriene antagonist
0,229  0,187  Atherosclerosis treatment
0,059  0,019  Factor III inhibitor
0,134  0,094  Eye irritation, high
0,122  0,085  Interleukin 1 antagonist
0,100  0,063  Chronic obstructive bronchitis treatment
0,107  0,070  SULT1A1 substrate
0,103  0,067  UGT2B1 substrate
0,140  0,105  Antiviral (Hepatitis C)
0,054  0,021  Mannosidase inhibitor
0,076  0,047  Telomerase inhibitor
0,085  0,056  Vanilloid agonist
0,047  0,018  Estrogen receptor alpha agonist
0,102  0,074  Mucolytic
0,137  0,111  Dual specificity phosphatase inhibitor
0,082  0,060  Antiviral (Trachoma)
0,171  0,151  5 Hydroxytryptamine release stimulant
0,133  0,113  Dual specificity phosphatase 3 inhibitor
0,139  0,120  Hearing loss treatment
0,031  0,014  1,3-Beta-glucan synthase inhibitor
0,224  0,209  Antiparkinsonian
0,100  0,085  Adenylate cyclase inhibitor
0,060  0,045  Transcription factor AP-1 inhibitor
0,130  0,115  Uterine stimulant
0,088  0,074  Sphingomyelinase inhibitor
0,045  0,033  Neuraminidase (Influenza A) inhibitor
0,131  0,120  Diabetic retinopathy treatment
0,115  0,104  Neurotrophic factor
0,085  0,076  Butyrylcholinesterase inhibitor
0,047  0,039  Antiviral (Herpesvirus 3, Human)
0,072  0,064  Estrogen receptor alpha antagonist
0,043  0,037  Microtubule stabilization
0,134  0,131  Diabetic nephropathy treatment
0,156  0,154  VEGF expression inhibitor
0,070  0,069  Cell adhesion molecule inhibitor
0,048  0,047  Carbonic anhydrase VB inhibitor

